Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026
Palantir is currently worth $269 billion, but certain Wall Street analysts think Intuitive Surgical and ServiceNow can top that figure in 2026.
ServiceNow is a leader in IT service management and IT operations software, and recently released AI products are driving revenue growth.
Intuitive Surgical is a technology leader in robotics-assisted surgical systems, and it recently won new approvals from the FDA.
Palantir Technologies is currently worth $269 billion. But these Wall Street analysts think Intuitive Surgical (NASDAQ: ISRG) and ServiceNow (NYSE: NOW) can top that figure in 2026:
Patrick Wood at Morgan Stanley has set Intuitive Surgical with a bull-case target price of $850 per share. That implies 64% upside from its current share price of $517. It also implies a market value of $304 billion.
Patrick Walravens at JMP Securities has set ServiceNow at a target price of $1,300 per share. That implies 36% upside from its current share price of $955. It also implies a market value of $270 billion.
Here's what investors should know about these stocks.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Intuitive Surgical is the leader in robotics-assisted surgery. It is best known for its da Vinci systems, which let surgeons perform minimally invasive procedures with greater precision in five areas:
General surgery
Urologic surgery
Gynecologic surgery
Cardiothoracic surgery
Head and neck surgery
The company also provides Ion systems for minimally invasive lung biopsies.
Importantly, Intuitive has a razor-and-blade business model. Surgical and diagnostic systems are the razors; they represent significant but infrequent expenses for healthcare facilities. And the adjacent instruments and accessories are the blades; they include consumable tools like scalpels and forceps that must be replaced with each procedure. The razor-and-blade model creates a steady revenue stream.
Intuitive Surgical reported strong first-quarter financial results that beat estimates on the top and bottom lines. Revenue rose 19% to $2.2 billion on strong growth in da Vinci procedures and system placements. Meanwhile, non-GAAP (generally accepted accounting principles) earnings rose 21% to $1.50 per diluted share.
Intuitive is well positioned to keep its momentum. Recently, the company won approvals from the Food and Drug Administration that let da Vinci systems perform more colorectal surgical procedures. In a note to clients, Morgan Stanley analyst Patrick Wood said the total addressable market is "larger than investors might appreciate." So, the new approval could lead to faster-than-expected growth in the coming quarters.
Wall Street says adjusted earnings will increase 10% annually through 2026, but analysts have often missed the mark. Intuitive Surgical beat the consensus estimate by an average of 14% in the last four quarters. If earnings grow at 28% annually -- equal to growth in 2024 -- through the third quarter of 2026, its market value could reach $270 billion without any change in the price-to-earnings (P/E) ratio.
However, Intuitive shares currently trade at 68 times earnings, an expensive valuation for a company forecast to grow earnings at 10% annually. So, my prediction is admittedly a long shot. The company would need a series of very strong financial results to top Palantir's current market value in 2026, and the bull-case target set by Morgan Stanley seems unlikely. Regardless, patient investors should consider buying a small position in this robotics stock today.
ServiceNow provides workflow management software that helps businesses organize and digitize processes across departments. Its core competency is IT software. It is the market leader in IT service management and artificial intelligence (AI) for IT operations software. Importantly, the company added generative AI features called Now Assist in 2023, and agentic AI capabilities in 2025.
ServiceNow reported solid financial results in the first quarter, beating estimates on the top and bottom lines. Revenue increased 18% to $3 billion, and non-GAAP net income increased 18% to $4.04 per diluted share. "ServiceNow's position as the platinum standard for enterprise-grade AI drove these outstanding first-quarter results," CEO Bill McDermott told analysts. "The software industrial complex is converging on ServiceNow as the AI operating system for the enterprise."
Wall Street expects ServiceNow's adjusted earnings to grow at 19% annually through 2026, but the company beat the consensus estimate by an average of 7% over the last six quarters. If that trend persists through the third quarter of 2026, trailing-12-month earnings would hit $20.10 per share. If ServiceNow keeps its current valuation of 66 times earnings, its share price would hit $1,325, implying 39% upside from the current price.
In that scenario, ServiceNow would hit a market value of $275 billion after reporting third-quarter financial results in 2026, more than Palantir is worth today. However, the current valuation is expensive for a company forecast to grow earnings at 19% annually, which means ServiceNow needs flawless execution to hit that mark.
Before you buy stock in Intuitive Surgical, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Intuitive Surgical wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $611,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $684,068!*
Now, it's worth noting Stock Advisor's total average return is 889% — a market-crushing outperformance compared to 162% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of April 28, 2025
Trevor Jennewine has positions in Palantir Technologies. The Motley Fool has positions in and recommends Intuitive Surgical, Palantir Technologies, and ServiceNow. The Motley Fool has a disclosure policy.
Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026 was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Toronto-listed Methanex shares rise as Israel-Iran war may boost methanol prices
-- Methanex (NASDAQ:MEOH) Corporation (TSX:MX) shares rose as much as 6% Friday in Toronto, marking the largest intraday gain since May, following Israel's attack on Iran. Methanex is "one of the world's largest exporters of seaborne methanol." While no methanol facilities were directly impacted in the initial attack, according to available information, Raymond James analyst Steve Hansen noted that identified potential indirect implications that could benefit the methanol sector. "Taken together, we expect these forces to lend upward pressure on Methanex shares," Hansen wrote in his analysis. Raymond James maintained its outperform rating on the methanol producer's stock amid the geopolitical developments. Related articles Toronto-listed Methanex shares rise as Israel-Iran war may boost methanol prices Nvidia GTC Paris is 'another bullish proof point' long term - Morgan Stanley Apple stock could catch a short-term bid with cheap valuation: Morgan Stanley Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
Apple stock could catch a short-term bid with cheap valuation: Morgan Stanley
-- Apple shares may benefit from short-term upside as deep discounting in China fuels stronger-than-expected iPhone and iPad sales, according to Morgan Stanley. 'iPhone and iPad sell-through in China are positively surprising this quarter thanks to 618 Festival promotion momentum,' Morgan Stanley analysts wrote, adding that the trend suggests 'up to $4B June revenue upside vs. MSe, all else equal.' 'Specifically, we now see ~3.0M units of upside to our June quarter iPhone shipments and ~2.5M units of upside to our June quarter iPad shipments,' the bank stated. China's 618 Festival promotions and national subsidies are said to have been key drivers, leading to 'very strong' iPhone sell-through for three consecutive weeks. The bank's Greater China Tech Hardware team now estimates 46.5 million iPhone builds and 14.5 million iPad builds in the June quarter, representing year-over-year growth of 19% and 38%, respectively. That's up from prior estimates of 45 million iPhones and 13 million iPads. Using historical seasonal relationships between builds and shipments, Morgan Stanley projects iPhone shipments to hit 49 million, which is '7% above MSe of 46.0M units, and 8% above Consensus at 45.2M.' For iPads, they now see 14.7 million shipments, '20% above MSe of 12.3M units, and 12% above Consensus.' While near-term Services growth uncertainty remains a concern for investors, Morgan Stanley stated: 'Estimate upside is typically accompanied by multiple expansion, so watch for Apple (NASDAQ:AAPL) to potentially catch a short-term bid given the stock is trading towards the lower-end of its 24-32x P/E range over the last 2 years.' Related articles Apple stock could catch a short-term bid with cheap valuation: Morgan Stanley Brookfield Infrastructure reportedly acquiring Hotwire for $7 billion Nvidia GTC Paris is 'another bullish proof point' long term - Morgan Stanley Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%
These stocks all pay more than 5% in dividends, and their payouts look safe. These companies have strong fundamentals, which can make them ideal investments to hold for the long term. 10 stocks we like better than Pfizer › Dividend income offers a great way to strengthen your overall financial position. It can potentially make you less dependent on the income you earn from a job, maybe even allowing you to work less or retire earlier than planned. Money doesn't buy happiness, but being less dependent on work to fund your lifestyle could be a contributor to a happier, less stressful life. A great way to build up dividend income is to invest in high-yielding dividend stocks that also happen to be lower-risk investments. Pfizer (NYSE: PFE), Realty Income (NYSE: O), and Bank of Nova Scotia (NYSE: BNS) are three attractive investments that you'll want to consider if you want to create a strong portfolio of income-generating stocks. If you're looking for a high-yielding stock to hold for the long term, Pfizer is one you'll want to strongly consider. At 7.4%, its yield right now is more than five times what you'd get with the average stock on the S&P 500, which pays about 1.3%. Pfizer's stock is trading down more than 10% this year (as of the end of last week), as it can't seem to catch a break. While its valuation is modest -- it trades at 17 times its trailing earnings -- concerns about healthcare reform and the company's future growth prospects have made investors uneasy about the business and investing in it. But the healthcare company is still doing well and is on track to hit its guidance, which calls for revenue between $61 billion and $64 billion this year (comparable to how it did last year). It is also slashing costs to improve its bottom line. And it has been less than two years since it acquired oncology company Seagen, which may unlock more long-term growth for Pfizer in the future. Last year, the company also obtained approval from regulators for its first gene therapy in the U.S. -- Beqvez, a treatment for a genetic bleeding disorder. There's some uncertainty and risk with Pfizer, but there are opportunities as well. And at such a modest valuation, now can be an excellent time to add it to your portfolio. Pfizer has been a big name in healthcare for decades, and I don't think that's likely to change anytime soon. One dividend stock I think all income investors should consider owning is Realty Income. This is a real estate investment trust (REIT) that not only offers a high yield of 5.8%, but it also pays a dividend every month. There's no need to wait around for multiple months, as is the case with other dividend stocks; with Realty Income, you're getting a much more regular stream of cash flow. The REIT has a diverse mix of tenants, which makes it an ideal option for long-term investors. It's diversified across industries and geographies, with more than 1,500 clients across 91 industries. The dividend remains well supported -- the REIT reported funds from operations (FFO) per share of $1.05 during the first three months of the year (versus $0.94 a year ago). That averages out to $0.35 per share per month, which is higher than the rate of its monthly dividend of $0.2685. REITs use FFO to assess how much they can afford to pay in dividends, and with Realty Income's financials looking solid, there aren't any significant risks with its payout. Share prices of Realty Income are up 5% this year, and this can be a great income-generating investment to add to your portfolio for the long haul. Rounding out this list of high-yielding dividend stocks is Canada-based Bank of Nova Scotia, also known as Scotiabank. At around 6%, that's a high payout for a top bank stock that is known for long-term stability. It declared its first dividend back in 1833 and has continued making regular payments since then. The bank increased its provision for credit losses in its most recent quarter, in a sign of growing concern about macroeconomic conditions. Scotiabank's net income totaled over $2 billion Canadian dollars for the period ending April 30, which was nearly identical to its bottom line in the prior-year period. There are concerns about how the Canadian economy may perform in the near future due to tariffs, but in the grand scheme of things, that may prove to be a short-term concern for investors who are willing to hang on for years. Scotiabank's impressive track record and resilience over the years should inspire some confidence in the business. The bank stock has increased its dividend by more than 22% in four years and can be an excellent option to hang on to for the long term. Not only can you collect a high yield today, but the dividend income you get from this investment can rise over the years. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer and Realty Income. The Motley Fool recommends Bank Of Nova Scotia. The Motley Fool has a disclosure policy. Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5% was originally published by The Motley Fool Sign in to access your portfolio
